Related Experiment Video
Updated: Mar 7, 2026
06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
1.6K
The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the
Cecilie Hurup Hansen1, Lizette Weber Larsen1, Amalie Møller Sørensen1
1Toxicology Laboratory, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 OE Copenhagen, Denmark.
Summary
Selective serotonin reuptake inhibitors (SSRIs) disrupt steroid hormone production in humans, affecting testosterone and estrogen levels. Further research is needed to understand the potential health risks for users.
Area of Science:
- Endocrinology
- Pharmacology
- Toxicology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are primary treatments for major depressive disorder (MDD).
- SSRIs are known to potentially impact the endocrine system and reproductive health.
Purpose of the Study:
- To investigate the endocrine-disrupting potential of six common SSRIs.
- To analyze the effects of SSRIs on the synthesis of major steroid hormones.
Main Methods:
- Utilized the OECD-standardized H295R human adrenocortical cell assay for in vitro testing.
- Quantified steroid hormone levels, including androgens and estrogens, using a validated LC-MS/MS method.
Main Results:
- All six SSRIs demonstrated endocrine-disrupting effects on steroidogenesis around maximum drug concentrations (Cmax).
- SSRIs consistently reduced testosterone levels through various mechanisms, including impacts on CYP17.
- A relative increase in the estrogen/androgen ratio was observed, suggesting aromatase stimulation.
Conclusions:
- SSRIs can interfere with steroid hormone production in human adrenal cells at clinically relevant concentrations.
- The findings highlight the need for further investigation into the potential endocrine-related hazards associated with SSRI use.
Related Concept Videos
01:22Target Cell Response to Hormones
6.0K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
6.0K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.9K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.9K
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.1K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.8K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.8K